Download presentation
Presentation is loading. Please wait.
1
Volume 83, Issue 3, Pages 511-516 (March 2013)
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease Helene Munyentwali, Khedidja Bouachi, Vincent Audard, Philippe Remy, Philippe Lang, Rachid Mojaat, Georges Deschênes, Pierre M. Ronco, Emmanuelle M. Plaisier, Karine Y. Dahan Kidney International Volume 83, Issue 3, Pages (March 2013) DOI: /ki Copyright © 2013 International Society of Nephrology Terms and Conditions
2
Figure 1 Number of relapses per year before and after rituximab treatment (*P<0.05). Results are the mean±s.d. Kidney International , DOI: ( /ki ) Copyright © 2013 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.